To the best of our knowledge, no prior reports have investigated the relationship between NAT2, CYP1A1, and CYP1A2 polymorphisms and HAAs as risk factors for prostate cancer in a Japanese population. This evidence concerns the gene CYP1A2 and Familial prostate cancer.